{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:31:01Z","timestamp":1760866261996,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jceh.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T01:52:11Z","timestamp":1596937931000},"page":"278-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Changing Nomenclature from Nonalcoholic Fatty Liver Disease\u00a0to Metabolic Dysfunction-Associated Fatty Liver Disease\u00a0\u2013 Not Only Premature But Also Confusing"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-2664","authenticated-orcid":false,"given":"Ajay","family":"Duseja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3901-6969","authenticated-orcid":false,"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2020.08.002_bib1","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","author":"Younossi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jceh.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jgh3.12117","article-title":"High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India","volume":"3","author":"Duseja","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/hep.23838","article-title":"Nonalcoholic fatty liver in a developing country is responsible for significant liver disease","volume":"52","author":"Duseja","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-Part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine society of India, Indian college of Cardiology and Indian society of Gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.08.002_bib9","first-page":"25A","article-title":"Characterizing and predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-obese non-alcoholic fatty liver disease (NAFLD) in Asia \u2013 the GOASIA initiative","volume":"70","author":"Jonathan Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2020.08.002_bib10","first-page":"46","article-title":"Nationwide registry on nonalcoholic fatty liver disease (NAFLD) - the ICON-D (Indian consortium on NAFLD) study","volume":"34","author":"Duseja","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320301134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320301134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:06:46Z","timestamp":1760854006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688320301134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0973688320301134"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2020.08.002","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing Nomenclature from Nonalcoholic Fatty Liver Disease\u00a0to Metabolic Dysfunction-Associated Fatty Liver Disease\u00a0\u2013 Not Only Premature But Also Confusing","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}